Gloom and Doom Meeting of docs Turns Hopeful When Patient Offers Health Reform Proposal
In Brief: Bresnick Directs Norris Cotton Cancer Center; FASEB Honors Kirschstein; Van Nevel’s 2th Year
Bosnian Research Trying To Leave, Asks For More Calls
ACS Urges Practice Of Insurance Exclusion End Under Reform
Epstein Petition Seeks Broder’s Removal As NCI Director
NIH Should Review CRADA Pricing, Wyden Write to Shalala
IOM Selects Advisors To Defense Department
“Alternative” Is Misleading Term, President’s Cancer Panel Writes To Healy
FDA Policy On Support Of Medical Education Near Final Form
Trending Stories
- As cancer scientists, we must change how we engage with the public on the impact of NIH cuts
What the scientific method obscures - In weekly vigils, current and former NIH staff grieve the impact of Trump cuts
The Saturday gatherings at NIH’s Metro station are part graveside service, part street theater - The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives
In a time of uncertainty, “react to the knowns, not the fear” - She flew Black Hawks and battled cancer—now Col. Susan Fondy grapples with cuts to lymphedema research
- First-ever financial toxicity tumor board aims to change the standard of care
Researchers focus on debt as a side effect of cancer, treatment amid cuts to Medicaid, NCI - Scaling excellence: How City of Hope is transforming cancer care delivery
